Back to Search
Start Over
The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors
- Source :
- Clinics and Research in Hepatology and Gastroenterology; June 2017, Vol. 41 Issue: 3 p311-318, 8p
- Publication Year :
- 2017
-
Abstract
- Patients with chronic hepatitis B virus (HBV) infection are at high risk for progressing to decompensated cirrhosis and hepatocellular carcinoma (HCC). Although long-term treatment with nucleos(t)ide analogues (NAs) benefits patients with chronic hepatitis B (CHB), many develop HCC. Therefore, the clinical outcomes of patients CHB who undergo long-term treatment with NAs remain to be identified. The aim of this study therefore was to evaluate the risk and predictors of patients with CHB who develop hepatitis B-induced HCC.
Details
- Language :
- English
- ISSN :
- 22107401
- Volume :
- 41
- Issue :
- 3
- Database :
- Supplemental Index
- Journal :
- Clinics and Research in Hepatology and Gastroenterology
- Publication Type :
- Periodical
- Accession number :
- ejs40754611
- Full Text :
- https://doi.org/10.1016/j.clinre.2016.11.007